Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.72
-0.055-0.29%
Last update: Oct 6, 4:58 PM
$18.88
0.110.56%
Legend Biotech Corp (LEGN) Stock Price, Quote, News & History
LEGNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.
Other companies in Legend Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Legend Biotech has a consensus price target of $64.40.
The stock price for Legend Biotech (NASDAQ: LEGN) is $18.88 last updated October 6, 2026 at 4:58 PM EDT.
There are no upcoming dividends for Legend Biotech.
Legend Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Legend Biotech.
Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
